The Diagnostic Ultrasound Enthesitis Tool (DUET) Study
Launched by WOMEN'S COLLEGE HOSPITAL · Oct 7, 2020
Trial Information
Current as of July 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- General Inclusion Criteria:
- • Age ≥18
- • Able to provide an informed consent
- Specific Inclusion Criteria for PsA:
- • Meets the CASPAR criteria for PsA
- • Early PsA - Less than 5 years from a rheumatologist diagnosis of PsA
- Specific Inclusion Criteria for Psoriasis:
- • Dermatologist confirmed diagnosis of psoriasis
- • No prior diagnosis of PsA or signs of PsA on physical examination
- • Psoriasis Epidemiology Screening Tool (PEST) score \< 3
- Specific Inclusion Criteria for non-inflammatory rheumatic disease:
- • Referred to rheumatology for musculoskeletal symptoms such as joint pain, stiffness, back pain
- • No evidence of inflammatory rheumatic condition including rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, scleroderma, gout, septic arthritis or recent joint trauma/surgery
- • No psoriasis
- • No inflammatory bowel disease
- Exclusion Criteria:
- • Using any biologic medications including Tumor Necrosis Factor (TNF) inhibitors, Interleukin (IL)-17 inhibitors, IL-23 inhibitors, IL-12/23 inhibitors, Janus Kinase (JAK) inhibitors
- • Prednisone ≥ 7.5 mg/day
About Women's College Hospital
Women's College Hospital (WCH) is a leading academic health sciences center in Toronto, dedicated to advancing women's health through innovative research, education, and exceptional patient care. As a progressive institution, WCH focuses on addressing the unique health needs of women, fostering groundbreaking clinical trials that contribute to the understanding and treatment of various health conditions. With a commitment to collaboration, WCH partners with various stakeholders, including academic institutions and healthcare organizations, to enhance the quality of care and improve health outcomes for women. Through its robust research programs, Women's College Hospital is at the forefront of shaping future healthcare practices and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Lihi Eder, MD, PhD
Principal Investigator
University of Toronto
Sibel Z Aydin, MD
Principal Investigator
University of Ottawa
Gurjit S Kaeley, MD
Principal Investigator
University of Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials